|
Most
common adverse events for subjects evaluable for toxicity.
|
IL-12
Dose (ng/kg)
|
0
|
10
|
30
|
100
|
|
Administration Route
(number of subjects)
|
s.c.
(4)
|
i.v.
(3)
|
s.c.
(6)
|
i.v.
(3)
|
s.c.
(3)
|
i.v.
(3)
|
s.c.
(3)
|
i.v.
(3)
|
|
Event
|
Toxicity
Gradea
|
Number
of Patients Exhibiting Event
|
|
Fever
|
less
than or equal to 2
|
-
|
-
|
2
|
-
|
-
|
3
|
-
|
3
|
|
3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Lethargy
|
less
than or equal to 2
|
-
|
3
|
-
|
3
|
-
|
3
|
1
|
1
|
|
3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Nausea
or vomiting
|
less
than or equal to 2
|
-
|
3
|
-
|
1
|
1
|
2
|
3
|
-
|
|
3
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
|
Pain,
including tumor pain
|
less
than or equal to 2
|
1
|
3
|
-
|
-
|
1
|
3
|
2
|
1
|
|
3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
|
Headache
|
less
than or equal to 2
|
-
|
2
|
-
|
1
|
-
|
3
|
-
|
1
|
|
3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
aUsing
NCI CTC criteria. There were no grade IV toxicities.
|